103 related articles for article (PubMed ID: 3339617)
1. Pyrido[2,1-b]quinazolinecarboxamide derivatives as platelet activating factor antagonists.
Tilley JW; Burghardt B; Burghardt C; Mowles TF; Leinweber FJ; Klevans L; Young R; Hirkaler G; Fahrenholtz K; Zawoiski S
J Med Chem; 1988 Feb; 31(2):466-72. PubMed ID: 3339617
[TBL] [Abstract][Full Text] [Related]
2. Biphenylcarboxamide derivatives as antagonists of platelet-activating factor.
Tilley JW; Clader JW; Zawoiski S; Wirkus M; LeMahieu RA; O'Donnell M; Crowley H; Welton AF
J Med Chem; 1989 Aug; 32(8):1814-20. PubMed ID: 2754708
[TBL] [Abstract][Full Text] [Related]
3. N-(heterocyclic alkyl)pyrido[2,1-b]quinazoline-8-carboxamides as orally active antiallergy agents.
Tilley JW; Levitan P; Lind J; Welton AF; Crowley HJ; Tobias LD; O'Donnell M
J Med Chem; 1987 Jan; 30(1):185-93. PubMed ID: 2879917
[TBL] [Abstract][Full Text] [Related]
4. Pentadienyl carboxamide derivatives as antagonists of platelet-activating factor.
Guthrie RW; Kaplan GL; Mennona FA; Tilley JW; Kierstead RW; Mullin JG; LeMahieu RA; Zawoiski S; O'Donnell M; Crowley H
J Med Chem; 1989 Aug; 32(8):1820-35. PubMed ID: 2754709
[TBL] [Abstract][Full Text] [Related]
5. Propenyl carboxamide derivatives as antagonists of platelet activating factor.
Guthrie RW; Kaplan GL; Mennona FA; Tilley JW; Kierstead RW; O'Donnell M; Crowley H; Yaremko B; Welton AF
J Med Chem; 1990 Oct; 33(10):2856-64. PubMed ID: 2170651
[TBL] [Abstract][Full Text] [Related]
6. Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF).
Merlos M; Giral M; Balsa D; Ferrando R; Queralt M; Puigdemont A; García-Rafanell J; Forn J
J Pharmacol Exp Ther; 1997 Jan; 280(1):114-21. PubMed ID: 8996188
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological activities of a novel thienodiazepine derivative as a platelet-activating factor antagonist.
Tsunoda H; Sakuma Y; Harada K; Muramoto K; Katayama S; Horie T; Shimomura N; Clark R; Miyazawa S; Okano K
Arzneimittelforschung; 1990 Nov; 40(11):1201-5. PubMed ID: 2085331
[TBL] [Abstract][Full Text] [Related]
8. Determination of the antiallergenic agent, N-[4-(1H-imidazol-1-yl)butyl]-2-(1-methylethyl)-11-oxo-11H- pyrido [2,1-b]quinazoline-8-carboxamide, in plasma by reversed-phase high-performance liquid chromatographic analysis using fluorometric detection.
Strojny N; Puglisi CV; de Silva JA
J Chromatogr; 1984 Dec; 336(2):301-11. PubMed ID: 6530462
[TBL] [Abstract][Full Text] [Related]
9. Novel antagonists of platelet-activating factor. 2. Synthesis and structure-activity relationships of potent and long-acting heterofused [1,5]benzodiazepine and [1,4]diazepine derivatives of 2-methyl-1-phenylimidazo[4,5-c]pyridine.
Fray MJ; Bull DJ; Cooper K; Parry MJ; Stefaniak MH
J Med Chem; 1995 Sep; 38(18):3524-35. PubMed ID: 7658439
[TBL] [Abstract][Full Text] [Related]
10. 11-Oxo-11H-pyrido[2,1-b]quinazoline-8-carboxylic acid, an orally active antiallergy agent.
Schwender CF; Sunday BR; Herzig DJ
J Med Chem; 1979 Jan; 22(1):114-6. PubMed ID: 423174
[TBL] [Abstract][Full Text] [Related]
11. Pharmacology of a potent platelet-activating factor antagonist: Ro 24-4736.
Crowley HJ; Yaremko B; Selig WM; Janero DR; Burghardt C; Welton AF; O'Donnell M
J Pharmacol Exp Ther; 1991 Oct; 259(1):78-85. PubMed ID: 1656030
[TBL] [Abstract][Full Text] [Related]
12. 1,4-Dihydropyridines as antagonists of platelet activating factor. 1. Synthesis and structure-activity relationships of 2-(4-heterocyclyl)phenyl derivatives.
Cooper K; Fray MJ; Parry MJ; Richardson K; Steele J
J Med Chem; 1992 Aug; 35(17):3115-29. PubMed ID: 1507200
[TBL] [Abstract][Full Text] [Related]
13. Derivatives of 2-methylenepropane-1,3-diol as new antagonists of platelet activating factor.
Grue-Sørensen G; Nielsen IM; Nielsen CK
J Med Chem; 1988 Jun; 31(6):1174-8. PubMed ID: 3373485
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and structure-activity relationship studies of novel 1-[(1-acyl-4-piperidyl)methyl]-1H-2- methylimidazo[4,5-c]pyridine derivatives as potent, orally active platelet-activating factor antagonists.
Carceller E; Merlos M; Giral M; Balsa D; García-Rafanell J; Forn J
J Med Chem; 1996 Jan; 39(2):487-93. PubMed ID: 8558517
[TBL] [Abstract][Full Text] [Related]
15. Biological effect of orally active platelet-activating factor receptor antagonist SM-10661.
Komuro Y; Imanishi N; Uchida M; Morooka S
Mol Pharmacol; 1990 Sep; 38(3):378-84. PubMed ID: 2402227
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationship in PAF-acether. 4. Synthesis and biological activities of carboxylate isosteres.
Wichrowski B; Jouquey S; Broquet C; Heymans F; Godfroid JJ; Fichelle J; Worcel M
J Med Chem; 1988 Feb; 31(2):410-5. PubMed ID: 3339611
[TBL] [Abstract][Full Text] [Related]
17. Biochemical and pharmacological activities of SR 27417, a highly potent, long-acting platelet-activating factor receptor antagonist.
Herbert JM; Bernat A; Valette G; Gigo V; Lale A; LaPlace MC; Lespy L; Savi P; Maffrand JP; Le Fur G
J Pharmacol Exp Ther; 1991 Oct; 259(1):44-51. PubMed ID: 1656029
[TBL] [Abstract][Full Text] [Related]
18. 2-(3-Pyridyl)thiazolidine-4-carboxamides. 1. Novel orally active antagonists of platelet-activating factor (PAF).
Nagaoka H; Hara H; Suzuki T; Takahashi T; Takeuchi M; Matsuhisa A; Saito M; Yamada T; Tomioka K; Mase T
Chem Pharm Bull (Tokyo); 1997 Oct; 45(10):1659-64. PubMed ID: 9353894
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor.
Heuer HO; Casals-Stenzel J; Muacevic G; Weber KH
J Pharmacol Exp Ther; 1990 Dec; 255(3):962-8. PubMed ID: 2262914
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, structure-activity relationships, and pharmacological evaluation of pyrrolo[3,2,1-ij]quinoline derivatives: potent histamine and platelet activating factor antagonism and 5-lipoxygenase inhibitory properties. Potential therapeutic application in asthma.
Paris D; Cottin M; Demonchaux P; Augert G; Dupassieux P; Lenoir P; Peck MJ; Jasserand D
J Med Chem; 1995 Feb; 38(4):669-85. PubMed ID: 7861415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
